-
1
-
-
0035815437
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
-
Amara, R. R., F. Villlnger, J. D. Altman, S. L. Lydy, S. P. O'Nell, S. I. Slaprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
-
(2001)
Science
, vol.292
, pp. 69-74
-
-
Amara, R.R.1
Villlnger, F.2
Altman, J.D.3
Lydy, S.L.4
O'Nell, S.P.5
Slaprans, S.I.6
Montefiori, D.C.7
Xu, Y.8
Herndon, J.G.9
Wyatt, L.S.10
Candido, M.A.11
Kozyr, N.L.12
Earl, P.L.13
Smith, J.M.14
Ma, H.L.15
Grimm, B.D.16
Hulsey, M.L.17
Miller, J.18
McClure, H.M.19
McNicholl, J.M.20
Moss, B.21
Robinson, H.L.22
more..
-
2
-
-
0035130148
-
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys
-
Barouch, D. H., A. Craiu, S. Santra, M. A. Egan, J. E. Schmitz, M. J. Kuroda, T. M. Fu, J. H. Nam, L. S. Wyatt, M. A. Lifton, G. R. Krivulka, C. E. Nickerson, C. I. Lord, B. Moss, M. G. Lewis, V. M. Hirsch, J. W. Shiver, and N. L. Letvin. 2001. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. J. Virol. 75:2462-2467.
-
(2001)
J. Virol.
, vol.75
, pp. 2462-2467
-
-
Barouch, D.H.1
Craiu, A.2
Santra, S.3
Egan, M.A.4
Schmitz, J.E.5
Kuroda, M.J.6
Fu, T.M.7
Nam, J.H.8
Wyatt, L.S.9
Lifton, M.A.10
Krivulka, G.R.11
Nickerson, C.E.12
Lord, C.I.13
Moss, B.14
Lewis, M.G.15
Hirsch, V.M.16
Shiver, J.W.17
Letvin, N.L.18
-
3
-
-
0033766645
-
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cylokine-augmented DNA vaccination
-
Bamuch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Lifton, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M. E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, and M. G. Lewis. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cylokine-augmented DNA vaccination. Science 29O:486-492.
-
(2000)
Science
, vol.290
, pp. 486-492
-
-
Bamuch, D.H.1
Santra, S.2
Schmitz, J.E.3
Kuroda, M.J.4
Fu, T.M.5
Wagner, W.6
Bilska, M.7
Craiu, A.8
Zheng, X.X.9
Krivulka, G.R.10
Beaudry, K.11
Lifton, M.A.12
Nickerson, C.E.13
Trigona, W.L.14
Punt, K.15
Freed, D.C.16
Guan, L.17
Dubey, S.18
Casimiro, D.19
Simon, A.20
Davies, M.E.21
Chastain, M.22
Strom, T.B.23
Gelman, R.S.24
Montefiori, D.C.25
Lewis, M.G.26
more..
-
4
-
-
0035341521
-
Safety and immunogenicity of a canary poxvectored human immunodeficiency virus type 1 vaccine with or without gp12O: A phase 2 study in higher- and lower-risk volunteers
-
Belshe, R. B., C. Stevens, G. J. Gorse, S. Buchbinder, K. Weinhold, Sheppard, D. Stablein, S. Self, J. MeNamara, S. Frey, J. Flores, J. L. Exeler, M. Klein, R. E. Habib, A.-M. Duliege, C. Harm, L. Corey, M. Keefer, M. Mulligan, P. Wright, C. Celum, F. Judson, K. Mayer, D. McKirnan, M. Marmor, G. Woody, the National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group, and the H. I. V. Network for Prevention Trials (HIVNET). 2001. Safety and immunogenicity of a canary poxvectored human immunodeficiency virus type 1 vaccine with or without gp12O: A phase 2 study in higher- and lower-risk volunteers. J. Infect. Dis. 183:1343-1352.
-
(2001)
J. Infect. Dis.
, vol.183
, pp. 1343-1352
-
-
Belshe, R.B.1
Stevens, C.2
Gorse, G.J.3
Buchbinder, S.4
Weinhold, K.5
Sheppard6
Stablein, D.7
Self, S.8
MeNamara, J.9
Frey, S.10
Flores, J.11
Exeler, J.L.12
Klein, M.13
Habib, R.E.14
Duliege, A.-M.15
Harm, C.16
Corey, L.17
Keefer, M.18
Mulligan, M.19
Wright, P.20
Celum, C.21
Judson, F.22
Mayer, K.23
McKirnan, D.24
Marmor, M.25
Woody, G.26
more..
-
5
-
-
0033551132
-
Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity
-
Belyakov, I. M., B. Moss, W. Strober, and J. A. Berzofsky. 1999. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc. Natl. Acad. Sci. USA 96:4512-4517.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 4512-4517
-
-
Belyakov, I.M.1
Moss, B.2
Strober, W.3
Berzofsky, J.A.4
-
6
-
-
0034666240
-
Recombinant viruses as a tool for fool to, therapeutic vaccination against human cancers
-
Bonnet, M. C., J. Tartaglia, F. Verdier, P. Kourilsky, A. Lindberg, M. Klein, and P. Moingeon. 2000. Recombinant viruses as a tool for fool to, therapeutic vaccination against human cancers, Immunol. Lett. 74:11-25.
-
(2000)
Immunol. Lett.
, vol.74
, pp. 11-25
-
-
Bonnet, M.C.1
Tartaglia, J.2
Verdier, F.3
Kourilsky, P.4
Lindberg, A.5
Klein, M.6
Moingeon, P.7
-
7
-
-
0014632609
-
Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome
-
Brandt, C. D., H. W. Kim, A. J. Vargosko, B. C. Jeffries, J. O. Arrobio, B. Rindge, R. H. Parrott, and R. M. Chanock. 1969. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am. J. Epidemiol. 90:484-500.
-
(1969)
Am. J. Epidemiol.
, vol.90
, pp. 484-500
-
-
Brandt, C.D.1
Kim, H.W.2
Vargosko, A.J.3
Jeffries, B.C.4
Arrobio, J.O.5
Rindge, B.6
Parrott, R.H.7
Chanock, R.M.8
-
8
-
-
0025963146
-
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprolein
-
Cooney, F. L., A. C. Collier, P. D. Greenberg, R. W. Coombs, J. Zarling, D. E. Arditti, M. C. Hoffman, S. L. Hu, and L. Corey. 1991. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprolein. Lancet 337:567-572.
-
(1991)
Lancet
, vol.337
, pp. 567-572
-
-
Cooney, F.L.1
Collier, A.C.2
Greenberg, P.D.3
Coombs, R.W.4
Zarling, J.5
Arditti, D.E.6
Hoffman, M.C.7
Hu, S.L.8
Corey, L.9
-
9
-
-
85025432190
-
Generation of recombinant vaccinia viruses
-
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). John Wiley & Sons, Inc., New York, N.Y.
-
Earl, P. L., B. Moss, L. S. Wyatt, and M. W. Carroll. 1998. Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.19. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York, N.Y.
-
(1998)
Current Protocols in Molecular Biology
, pp. 16171-161719
-
-
Earl, P.L.1
Moss, B.2
Wyatt, L.S.3
Carroll, M.W.4
-
10
-
-
0036056987
-
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model
-
Earl, P. L., L. S. Wyatt, D. C. Montefiori, M. Bilska, R. Woodward, P. D. Markham, J. D. Malley, T. U. Vogel, T. M. Allen, D. I. Watkins, N. Miller, and B. Moss. 2002. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Virology 294:270-281.
-
(2002)
Virology
, vol.294
, pp. 270-281
-
-
Earl, P.L.1
Wyatt, L.S.2
Montefiori, D.C.3
Bilska, M.4
Woodward, R.5
Markham, P.D.6
Malley, J.D.7
Vogel, T.U.8
Allen, T.M.9
Watkins, D.I.10
Miller, N.11
Moss, B.12
-
11
-
-
0035164962
-
Replication-defective vector based on a chimpanzee adenovirus
-
Farina, S. F., G.-P. Gao, Z. Q. Xlang, J. J. Rux, R. M. Burnett, M. R. Alvira, J. Marsh, H. C. J. Ertl, and J. M. Wilson. 2001. Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75:11603-11613.
-
(2001)
J. Virol.
, vol.75
, pp. 11603-11613
-
-
Farina, S.F.1
Gao, G.-P.2
Xlang, Z.Q.3
Rux, J.J.4
Burnett, R.M.5
Alvira, M.R.6
Marsh, J.7
Ertl, H.C.J.8
Wilson, J.M.9
-
12
-
-
0034046182
-
DNA vaccines: Immunology, application, and optimization
-
Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: Immunology, application, and optimization. Annu. Rev. Immunol. 18:927-974.
-
(2000)
Annu. Rev. Immunol.
, vol.18
, pp. 927-974
-
-
Gurunathan, S.1
Klinman, D.M.2
Seder, R.A.3
-
13
-
-
0000089873
-
Adenoviruses
-
D. M. Knipe and P. M. Howley (ed.). Lippincott, Williams & Wilkins, Philadelphia, Pa
-
Horwitz, M. S. 2001. Adenoviruses, p. 2301-2326. In D. M. Knipe and P. M. Howley (ed.), Fields Virology, 4th Ed. Lippincott, Williams & Wilkins, Philadelphia, Pa.
-
(2001)
Fields Virology, 4th Ed.
, pp. 2301-2326
-
-
Horwitz, M.S.1
-
14
-
-
0012075064
-
A study of illness in a group of Cleveland families. X. The occurrence of adenovirus infections
-
Jordan, W. S., G. F. Badger, C. Curtiss, J. H. Dingle, H. S. Ginsberg, and E. Gold. 1956. A study of illness in a group of Cleveland families. X. The occurrence of adenovirus infections. Am. J. Hyg. 64:336-348.
-
(1956)
Am. J. Hyg.
, vol.64
, pp. 336-348
-
-
Jordan, W.S.1
Badger, G.F.2
Curtiss, C.3
Dingle, J.H.4
Ginsberg, H.S.5
Gold, E.6
-
15
-
-
0031772993
-
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
-
Kent, S. J., A. Zhao, S. J. Best, J. D. Chandler, D. B. Boyle, and I. A. Ramshaw. 1998. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180-10188.
-
(1998)
J. Virol.
, vol.72
, pp. 10180-10188
-
-
Kent, S.J.1
Zhao, A.2
Best, S.J.3
Chandler, J.D.4
Boyle, D.B.5
Ramshaw, I.A.6
-
16
-
-
0033989650
-
Canine adenovirus vectors: An alternative for adenovirus-mediated gene transfer
-
Kremer, E. J., S. Boutin, M. Chillon, and O. Danos. 2000. Canine adenovirus vectors: An alternative for adenovirus-mediated gene transfer. J. Virol. 74:505-512.
-
(2000)
J. Virol.
, vol.74
, pp. 505-512
-
-
Kremer, E.J.1
Boutin, S.2
Chillon, M.3
Danos, O.4
-
17
-
-
0033037009
-
ELISA for the detection of antibodies to Ebola viruses
-
Ksiazek, T. G., C. P. West, P. E. Rollin, P. B. Jahrling, and C. J. Peters. 1999. ELISA for the detection of antibodies to Ebola viruses. J. Infect. Dis. 179:S192-S198.
-
(1999)
J. Infect. Dis.
, vol.179
-
-
Ksiazek, T.G.1
West, C.P.2
Rollin, P.E.3
Jahrling, P.B.4
Peters, C.J.5
-
18
-
-
0029976870
-
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
-
Moss, B. 1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA 93:11341-11348
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 11341-11348
-
-
Moss, B.1
-
19
-
-
0035912191
-
Challenges and opportunities for development of an AIDS vaccine
-
Nabel, G. J. 2001. Challenges and opportunities for development of an AIDS vaccine. Nature 410:1002-1007.
-
(2001)
Nature
, vol.410
, pp. 1002-1007
-
-
Nabel, G.J.1
-
20
-
-
0029957222
-
Applications of pox virus vectors to vaccination: An update
-
Paoletti, E. 1996. Applications of pox virus vectors to vaccination: An update. Proc. Natl. Acad. Sci. USA 93:11349-11353.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 11349-11353
-
-
Paoletti, E.1
-
21
-
-
9844239902
-
DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors
-
Ramsay, A. J., K. H. Leong, and I. A. Ramshaw. 1997. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol. Cell Biol. 75:382-388.
-
(1997)
Immunol. Cell Biol.
, vol.75
, pp. 382-388
-
-
Ramsay, A.J.1
Leong, K.H.2
Ramshaw, I.A.3
-
22
-
-
0023937721
-
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: Long-term protection and effect of revaccination
-
Rooney, J. F., C. Wohlenberg, K. J. Cremer, B. Moss, and A. L. Notkins. 1988, Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: Long-term protection and effect of revaccination. J. Virol. 62:1530-1534.
-
(1988)
J. Virol
, vol.62
, pp. 1530-1534
-
-
Rooney, J.F.1
Wohlenberg, C.2
Cremer, K.J.3
Moss, B.4
Notkins, A.L.5
-
23
-
-
17944369239
-
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
-
Rose, N. F., P. A. Marx, A. Luckay, D. F. Nixon, W. J. Moretto, S. M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J. K. Rose. 2001. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549.
-
(2001)
Cell
, vol.106
, pp. 539-549
-
-
Rose, N.F.1
Marx, P.A.2
Luckay, A.3
Nixon, D.F.4
Moretto, W.J.5
Donahoe, S.M.6
Montefiori, D.7
Roberts, A.8
Buonocore, L.9
Rose, J.K.10
-
24
-
-
0023235389
-
Antibody response to enteric adenovirus types 40 and 41 in sera from people in various age groups
-
Shinozaki, T., K. Araki, H. Ushijima, and R. Fujii. 1987. Antibody response to enteric adenovirus types 40 and 41 in sera from people in various age groups. J. Clin. Microbiol. 25:1679-1682.
-
(1987)
J. Clin. Microbiol.
, vol.25
, pp. 1679-1682
-
-
Shinozaki, T.1
Araki, K.2
Ushijima, H.3
Fujii, R.4
-
25
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
Shiver, J. W., T. M. Fu, L. Chen, D. R. Casimiro, M. E. Davies, R. K. Evans, Z. Q. Zhang, A. J. Simon, W. L. Trigona, S. A. Dubey, L. Huang, V. A. Harris, R. S. Long, X. Liang, L. Handt, W. A. Schleif, L. Zhu, D. C. Freed, N. V. Persaud, L. Guan, K. S. Punt, A. Tang, M. Chen, K. A. Wilson, K. B. Collins, G. J. Heidecker, V. R. Fernandez, H. C. Perry, J. G. Joyce, K. M. Grimm, J. C. Cook, P. M. Keller, D. S. Kresock, H. Mach, R. D. Troutman, L. A. Isopi, D. M. Williams, Z. Xu, K. E. Bohannon, D. B. Volkin, D. C. Montefiori, A. Miura, G. R. Krivulka, M. A. Lifton, M. J. Kuroda, J. E. Schmitz, N. L. Letvin, M. J. Caulfield, A. J. Bett, R. Youil, D. C. Kaslow, and E. A. Emini. 2002, Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335.
-
(2002)
Nature
, vol.415
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.M.2
Chen, L.3
Casimiro, D.R.4
Davies, M.E.5
Evans, R.K.6
Zhang, Z.Q.7
Simon, A.J.8
Trigona, W.L.9
Dubey, S.A.10
Huang, L.11
Harris, V.A.12
Long, R.S.13
Liang, X.14
Handt, L.15
Schleif, W.A.16
Zhu, L.17
Freed, D.C.18
Persaud, N.V.19
Guan, L.20
Punt, K.S.21
Tang, A.22
Chen, M.23
Wilson, K.A.24
Collins, K.B.25
Heidecker, G.J.26
Fernandez, V.R.27
Perry, H.C.28
Joyce, J.G.29
Grimm, K.M.30
Cook, J.C.31
Keller, P.M.32
Kresock, D.S.33
Mach, H.34
Troutman, R.D.35
Isopi, L.A.36
Williams, D.M.37
Xu, Z.38
Bohannon, K.E.39
Volkin, D.B.40
Montefiori, D.C.41
Miura, A.42
Krivulka, G.R.43
Lifton, M.A.44
Kuroda, M.J.45
Schmitz, J.E.46
Letvin, N.L.47
Caulfield, M.J.48
Bett, A.J.49
Youil, R.50
Kaslow, D.C.51
Emini, E.A.52
more..
-
26
-
-
0034735774
-
Development of a preventive vaccine for Ebola virus infection in primates
-
Sullivan, N. J., A. Sanchez, P. E. Rollin, Z.-Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605-609.
-
(2000)
Nature
, vol.408
, pp. 605-609
-
-
Sullivan, N.J.1
Sanchez, A.2
Rollin, P.E.3
Yang, Z.-Y.4
Nabel, G.J.5
-
27
-
-
0031764996
-
Canarypox virus-based vaccines: Prime-boost strategies to induce cell-mediated and humoral immunity against HIV
-
Tartaglia, J., J. L. Excler, R. El Habib, K. Limbach, B. Meignier, S. Plotkin, and M. Klein. 1998. Canarypox virus-based vaccines: Prime-boost strategies to induce cell-mediated and humoral immunity against HIV. AIDS Res. Hum. Retrovir. 14(Suppl. 3):S291-S298.
-
(1998)
AIDS Res. Hum. Retrovir.
, vol.14
, Issue.SUPPL. 3
-
-
Tartaglia, J.1
Excler, J.L.2
El Habib, R.3
Limbach, K.4
Meignier, B.5
Plotkin, S.6
Klein, M.7
-
28
-
-
0036187846
-
Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product
-
Xiang, Z., G. Gao, A. Reyes-Sandoval, C. J. Cohen, Y. Li, J. M. Bergelson, J. M. Wilson, and H. C. Ertl. 2002. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J. Virol. 76:2667-2675.
-
(2002)
J. Virol.
, vol.76
, pp. 2667-2675
-
-
Xiang, Z.1
Gao, G.2
Reyes-Sandoval, A.3
Cohen, C.J.4
Li, Y.5
Bergelson, J.M.6
Wilson, J.M.7
Ertl, H.C.8
-
29
-
-
0031913871
-
Immunization for Ebola virus infection
-
Xu, L., A. Sanchez, Z. Yang, S. R. Zaki, E. G. Nabel, S. T. Nichol, and G. J. Nabel. 1998. Immunization for Ebola virus infection. Nat. Med. 4:37-42.
-
(1998)
Nat. Med.
, vol.4
, pp. 37-42
-
-
Xu, L.1
Sanchez, A.2
Yang, Z.3
Zaki, S.R.4
Nabel, E.G.5
Nichol, S.T.6
Nabel, G.J.7
-
30
-
-
0033831191
-
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
-
Yang, Z.-Y., H. J. Duckers, N. J. Sullivan, A. Sanchez, E. G. Nabel, and G. J. Nabel. 2000. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6:886-889.
-
(2000)
Nat. Med.
, vol.6
, pp. 886-889
-
-
Yang, Z.-Y.1
Duckers, H.J.2
Sullivan, N.J.3
Sanchez, A.4
Nabel, E.G.5
Nabel, G.J.6
|